Studying CBD
No Result
View All Result
  • Home
  • CBD
  • About CBD
  • What is CBD
  • Home
  • CBD
  • About CBD
  • What is CBD
No Result
View All Result
Studying CBD
No Result
View All Result
Home CBD

Pure Global Cannabis Strikes Deal To Produce, Export CBD Products From Chinese Facility

Peter F. by Peter F.
September 25, 2019
in CBD
38 2
0
Nonprofit Releases Results Of Wide-Ranging Survey
32
SHARES
360
VIEWS
Share on TwitterShare on Facebook

[ad_1]

Pure Global Cannabis Inc. (OTC: PRCNF) became the second company Tuesday to announce a CBD deal with an East Asian country, following on the heels of an earlier announcement from New Age Beverages Corp (NASDAQ: NBEV).  

The Canadian LP announced that it has secured an agreement through its wholly owned subsidiary PureSinse Inc. with KMT-Hansa Corp., a Chinese hemp production company registered in Anguilla.

“We are extremely excited to be the first Canadian LP to partner with a Chinese group seeking to develop a project of this scale in China. This strategic relationship gives us access to KMT’s resources and connections in China. They truly share our goal of providing high-quality products that are sustainable to the environment and developed using cutting-edge agricultural methods,” Pure Global President and CEO Malay Panchal said in a statement. 

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.

Per the agreement, KMT-Hansa will grow, extract, process and export CBD products at a 17,000-acre facility located in China’s Yunnan province.

KMT-Hansa was granted a Hemp International Industry Park Special Economic Zone License by Yuanjiang County in Yuxi City, Yunnan Province. The license allows the Anguillian company to grow, cultivate, extract and produce industrial hemp products for export. The licensing process is expected to be completed within the next two months while operations are being set up.

Pure Global said it will manage and develop the project by overseeing operations, developing GMP standard and managing the sale and distribution of the CBD products.

The Canadian company will also invest its technology and genetic know-how in the project.

RELATED  KC-based CBD chain is booming, but its strategies are controversial | News, Sports, Jobs

The two companies expect to move their finalized CBD products throughout Asia and 50 other international legal markets.

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[ad_2]

Source link

Tweet8Share13Share3Share
Peter F.

Peter F.

We study the effects of cannabidiol (CBD), a non-psychoactive component of cannabis that does not produce the high associated with smoking or using it."There is a lot of debate on the health effects of marijuana and the use of cannabinoids, which are a group of compounds found in marijuana that have anti-inflammatory, pain-relieving, anti-nausea and anti-emetic properties. However, there is a lack of solid scientific evidence to guide us in the application of cannabis therapeutics."

No Result
View All Result
  • Privacy Policy
  • Contact
  • About us

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.. For more information contact Info@sdmediagrp.comContinuePrivacy policy